Краткий обзор инструментов брендинга в том числе Вербальной айдентики (нейминг, слоганы, tone of voice) Теория и практические инструменты
Брендинговое агентство SHISHKI
Briefly about branding tools. Verbal Identity (naming, slogans, motos, tone of voice) Bit of theory and practical tools
SHISHKI branding agency
Adolescència i sexualitat. 15 decembre IES Sollana."Escola de pares"Ampa Ies Sollana
Els adolescents que tenen bones converses sobre sexualitat amb els pares són més propensos a posposar l’activitat sexual, a tindre menys parelles i a gastar presservatius i altres mitjos anticonceptius per a tindre relacions sexuals.
No és fácil parlar de temes que moltes vegades inclús ells poden saber més que nosaltres. Cóm poder començar a interactuar amb ells amb els temes de sexualitat?
Hem parlar amb els nostres fills i construir unes relacions sòlides amb ells, i ajudar-li a fixar-se expectatives i límits. Una bona información ajuda a previndre embaraços no desitjats i redueixen les possibilitats de malalties de transmissió sexual.
Amb aquesta xerrada-col·loqui aprendrem noves eines per acompanyar als nostres fills i filles amb seu camí de creixement i descobriments cap a la maduresa.
I per tant, cal començar a parlar!!
Краткий обзор инструментов брендинга в том числе Вербальной айдентики (нейминг, слоганы, tone of voice) Теория и практические инструменты
Брендинговое агентство SHISHKI
Briefly about branding tools. Verbal Identity (naming, slogans, motos, tone of voice) Bit of theory and practical tools
SHISHKI branding agency
Adolescència i sexualitat. 15 decembre IES Sollana."Escola de pares"Ampa Ies Sollana
Els adolescents que tenen bones converses sobre sexualitat amb els pares són més propensos a posposar l’activitat sexual, a tindre menys parelles i a gastar presservatius i altres mitjos anticonceptius per a tindre relacions sexuals.
No és fácil parlar de temes que moltes vegades inclús ells poden saber més que nosaltres. Cóm poder començar a interactuar amb ells amb els temes de sexualitat?
Hem parlar amb els nostres fills i construir unes relacions sòlides amb ells, i ajudar-li a fixar-se expectatives i límits. Una bona información ajuda a previndre embaraços no desitjats i redueixen les possibilitats de malalties de transmissió sexual.
Amb aquesta xerrada-col·loqui aprendrem noves eines per acompanyar als nostres fills i filles amb seu camí de creixement i descobriments cap a la maduresa.
I per tant, cal començar a parlar!!
Every business begins with a set of assumptions. It lays out a strategy - which includes a business model, a product road map, a point of view about partners and competitors, and ideas about who the customer will be - that takes those assumptions as a given and proceeds to show how to achieve the company's vision.
The truth is that a startup is an organization operating under conditions of extreme uncertainty and in search of a scalable, repeatable, profitable business model: the assumptions haven't been proved to be true (they are assumptions, after all) and they are often erroneous, thus the goal of a startup's early efforts should be to test them as quickly as possible.
The Lean Startup methodology reconceives a startup's efforts as experiments that test its strategy to see which parts are brilliant and which are crazy, with the final goal to discover how to build a sustainable business around that vision.
We know that startups are highly uncertain, but uncertainty and risk aren't the same thing!
Hampered with faltering economies, squeezed budgets
and aging populations, the healthcare systems of Europe’s
major markets are firmly focused on providing cost-effective
outcomes. Although each country has specific market access
requirements, Health Technology Assessment (HTA) has
become an essential input into pricing and reimbursement
decisions and clinical guidance on the use of innovative
technologies across Europe.
Though HTA practices differ across and within national
boundaries, specific themes have emerged.In particular,
demands for evidence of clinical and/or economic benefit on
new health technologies are increasing.
Pricing and reimbursement negotiations are becoming
increasingly difficult, as cost-containment strategies—
including reference pricing, limiting reimbursement for
drugs assessed to lack cost-effectiveness, and retroactively
assessing drugs already on the market—are being
implemented in various ways across Europe.
This document has been put together with our leading market access experts compiled together from number of primary research published by our team recently.
Feel free to reach out on msheikh@teamdrg.com if you would like to talk more about our analysis in this space and how we could support with any specific questions you may have.
About US: DRG's Research and Data portfolio delivers industry-leading primary research and insights. We provide our customers with a baseline for market intelligence.
Facebook: friend or foe to job seekers? Here are some tips to control what you share on to help make this "cocktail party" setting work to your advantage while advancing your career.
Check out slides from this 45-minute webcast to see what your organization needs to do to stay on top of the coming technology transformations and gain insight into upcoming trends in analytics.
View the webcast recording at: http://ow.ly/Rnu3307Umb9